Improving Access to Blood Cancer Trials for Black & Pakistani communities
Developing communications materials to improve engagement in blood cancer clinical trials for Blood Cancer UK and a top-10 pharmaceutical company

Overview 

Egality supported Blood Cancer UK to translate existing community insight into inclusive, culturally relevant clinical trial communications. The aim was to improve awareness, understanding, and trust among Black and Pakistani communities, and to ultimately to increase participation in clinical trials

Blood Cancer UK had previously conducted workshops and interviews with community members to explore perceptions, concerns, and barriers related to clinical trial participation. Building on this foundation, Egality analysed the existing insights and supported the development of communication outputs designed to increase public awareness and help people make informed decisions about taking part in clinical trials. 

You can read more about this project here. 

Our Approach 

Egality took an insight-led, community-validated approach. Findings from existing workshops and interviews were analysed and synthesised to identify key themes, which were mapped directly to action. These insights informed communication objectives, formats, tone, and the most appropriate channels. 

Proposed outputs were then tested through a validation workshop with Black and Pakistani community members. Feedback highlighted a strong preference for relatable, visual, and conversational content. This feedback was incorporated to ensure all materials were culturally relevant, accessible, and grounded in lived experience.

Outputs

Based on the validated insight, Egality co-developed a suite of tailored, video-led communication materials. 

The outputs included a series of six short videos featuring healthcare professionals, community researchers, and people with lived experience of blood cancer and clinical trials. The videos focused on: 

  • What a clinical trial is 
  • Busting common myths and misconceptions 
  • Why clinical trials matter 
  • Why someone might consider taking part 
  • Why it is important for the Black and Pakistani communities 
  • Personal and patient journey stories 

Subtitled versions in Urdu were also developed to support accessibility for Pakistani communities. These videos can be accessed here.

These materials are designed for use across Blood Cancer UK’s channels and partner networks to improve understanding of clinical trials and support greater equity in access and participation. 

More information about this project by Blood Cancer UK is available here.

This project/resource has been funded by Bristol Myers Squibb. The company had no input in the content.

"Working with Egality on an ambitious project with tight deadlines gave us confidence from the outset. The project felt secure and well-managed thanks to Egality’s highly collaborative approach. Communication was clear and consistent, and any challenges we encountered were addressed promptly and professionally. The pace and quality of Egality’s work not only ensured that we met our deadlines, but also that we delivered outcomes of an exceptionally high standard. Their efficient and collaborative way of working enabled us to work as 'one team', turning around high quality, co-created products in a very short time frame. Their knowledge and experience was clear from the outset, and their broad networks and talented film makers helped us turn our product vision into reality."
Lucy Packer & Kate Keightley
Service Transformation Lead & Deputy Director of Support and Clinical Services, Blood Cancer UK.

Read more case studies

Enhancing Patient Inclusion and Involvement with a Top-10 Pharmaceutical Company

Co-produced workshops with lived experience partners and pharmaceutical company

STEADFAST Study

Recruiting young people with type 1 diabetes

Supporting a UKRI Public Engagement Project

Recruiting people from diverse ethnic groups across the UK for deliberative workshops on the use of 'synthetic data' in research

Take one step to create health equity today